Lutein Supplementation May Improve Outcomes in Early AMD

Meta-analysis found statistically significant improvements, with clearest benefits in early-stage disease

1

Lutein supplementation improves macular pigment optical density and best-corrected visual acuity in early-stage age-related macular degeneration.
2

The systematic review analyzed nine randomized trials involving 860 patients, showing significant benefits of lutein compared to placebo.
3

Improvements in visual outcomes were statistically significant for early-stage AMD but not for late-stage or mixed-stage populations.
4

Longer supplementation duration and higher cumulative lutein exposure correlated with greater changes in visual outcomes.
5

The study highlights the need for longer follow-up to assess lutein's effects on AMD progression and long-term vision outcomes.

1